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Letters to the Editor / JAMDA 20 (2019) 99e106100It is difficult to disentangle what measures of muscle strength
should be used for accurately assessing dynapenia in aging adults.
The ages and functional capacities of individuals undergoing
muscle strength assessments and setting (clinical or epidemio-
logical) should be deliberated before testing. For example, older
adults with poor function may have difficulty performing KES
measurements; however, younger and middle-aged adult pop-
ulations could more easily provide measures of both HGS and KES.
Similarly, large epidemiological studies that are examiningmuscle
strength should use HGS for feasibility purposes, whereas imaging
in clinical settings may provide detailed insights into the age-
related changes of the musculoskeletal system (eg, bone, muscle
quality, articular cartilage).10 Therefore, it is important to consider
the balance between feasibility and validity in assessments of
muscle strength. Figure 1 provides a depiction for how measures
of muscle strength fit on a smoothed feasibility and validity slope.
Although researchers and health care providers should consider
feasibility and validity of muscle strength measurements, the
demographic factors, setting, and health outcomes being evalu-
ated should also be contemplated when selecting muscle strength
assessment modes.
The debate on how to appropriately measure muscle strength in
aging adults will continue. More research is needed to develop a
process for evaluating muscle strength during aging that ac-
knowledges age, standardization, setting, functional capacity,
feasibility, validity, and what clinically relevant health outcomes
are being examined. Doing so will help to develop consistency in
methods for researchers, health care providers, and their patients.
Additionally, more research that identifies how much accuracy is
gained by performing dynamometry at multiple sites on the body,
while also accounting for demographic factors, functional capacity,
setting, and health outcomes is needed to determine if the infor-
mation gained from both KES and HGS measurements outweighs
the feasibility and robust information that HGS alone already
provides.
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https://doi.org/10.1016/j.jamda.2018.07.011Response to the Letter to the
Editor: “Understanding the
Feasibility and Validity of
Muscle Strength Measurements
in Aging Adults”Thank you for the response to our recent article “Handgrip
Strength Cannot Be Assumed a Proxy for Overall Muscle Strength”.1
There are ample epidemiologic studies underlining handgrip
strength (HGS) as a powerful biomarker for health; lower HGS is
associated with negative health outcomes in older adults.2
However, in our previous study among community-dwelling
older adults visiting an outpatient clinic due to mobility im-
pairments, HGS showed weaker associations with health char-
acteristics compared to knee extension strength (KES) in the
same individuals.3 The difference in the association between
HGS and KES with health outcomes might be partly dependent
on population characteristics. In a large cohort of community-
dwelling individuals, both HGS and KES were equally predic-
tive for functional performance, whereas KES was a better
predictor of functional performance than HGS in older adults in
assisted living facilities.4
It should also be noted that HGS is not as sensitive as KES to
physical interventions. Tieland et al showed that substantial
improvement in KES as high as 40% was observed after a whole-
body resistance-type exercise program in frail older individuals,
but no change in HGS was detected.5 Furthermore, a recent meta-
analysis revealed that KES significantly improved, but HGS was
not, after exercise interventions targeting older adults with sarco-
penia.6 Therefore, HGS does not represent an appropriate measure
to evaluate the efficacy of interventions to increase muscle strength
or mass in older adults.
There is no doubt that HGS is easier to measure than KES.
However, the use of HGS alone is likely tomisclassify individuals for
dynapenia as HGS only explains about 40% of the variance of lower
extremity strength.7 We agree that there are feasibility issues
measuring KES, such as the availability of standardized equipment
and the need for special training. However, KES isokinetic dyna-
mometry has been validated and found to have high interrater and
intrarater reliability in older adults.8 For a portable, easy-to-use,
and less costly option, handheld dynamometer has been shown
to have high test-retest reliability in older adults.9 Based on our
experience in epidemiologic studies and in geriatric outpatient
clinics, where the measurement of KES is part of usual care, it is
feasible to measure KES even in frail patients. It is understood that
equipment for measuring KES is not readily available in most
outpatient clinics; therefore, Manini and Clark suggested that
referral to a separate assessment venue, such as physiotherapy
clinic or specialized clinic where equipment is available, would be
an approach for measuring KES.10 However, because patients
attending geriatric outpatient clinics are likely to suffer from sar-
copenia and/or dynapenia, investment in equipment is strongly
recommended.
Overall, the use of KES measurement in clinical practice is
feasible and should be encouraged because of its additional value
compared to HGS. We agree with the authors that further studies
are required to reach a standardized procedure in muscle strengthThe authors declare no conflict of interest.
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research and clinical settings.References
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https://doi.org/10.1016/j.jamda.2018.09.005Preventing Alzheimer’s Disease:
Why Not Targeting the Muscle
First?Alzheimer’s disease (AD) is the commonest cause of dementia
and in fact the most frequent neurologic disorder that accompanies
the ageing process, currently affecting more than 30 million per-
sons around the world.1 Although research is rapidly progressing,Funding sources: PLV is supported by a predoctoral contract granted by the
University of Alcalá (FPI2016). JSM is supported by a predoctoral contract granted
by Spanish Ministry of Education, Culture and Sport (FPU14/03435). Research in the
field of aging by A. Lucia is funded by Fondo de Investigaciones Sanitarias (FIS, grant
#PI15/00558) and Fondos FEDER.AD prevalence continues to rise worldwide, and currently available
treatments produce minimal improvements, prompting the need
for new strategies, including nonpharmacologic approaches. In this
regard, a key lifestyle intervention, regular physical activity (PA),
might play a major role in AD prevention,2 with the pandemic of
physical inactivity being at odds with our biological makeup. Our
species is indeed unique compared to the rest of hominoids in that
the increase in aerobic fitness that occurred as we evolved as
persistent hunters or “endurers” paralleled a remarkable increase
in cognition.3
There is evidence that PA is needed to maintain brain health
over life. Regular PA has positive effects on hippocampal volume,
preventing the decreases that occur as we age.4 Because the
hippocampus is one of the major brain sites of neuroplasticity,
this promising finding suggests the need for implementing PA
interventions to attenuate age-related neurologic decline. In fact,
a meta-analysis of 15 prospective studies (including 33,816
nondemented subjects followed for 1-12 years) found that in-
dividuals with high-to-moderate levels of PA reduced their risk of
cognitive decline by 35% to 38% compared to their sedentary
peers.5 There is also meta-analytic evidence in support of PA
implementation to prevent AD: our group showed that adher-
ence to the World Health Organization recommendations (ie,
150 minutes/wk of moderate-vigorous PA such as brisk
walking) at late life (70-80 years) is associated with a remarkable
(40%) reduction in the risk for AD.6 PA can also attenuate the
decline in cognitive function in individuals who already have
dementia, including those with AD.7 On the other hand, a crucial
problem of patients with AD that can be reverted, at least in part,
with PA interventions is physical deterioration and reduced
muscle mass, which in turn are linked to higher risks of falls and
fractures, decline in mobility, poorer quality of life, and further
loss of independence.8
More research is needed for a better and more balanced un-
derstanding of the pathogenesis of AD. In this regard, exercise
models might provide interesting insights. A recent preclinical
study showed that inducing hippocampal neurogenesis per se
(pharmacologically and genetically) did not confer any benefits
over AD markers.9 By contrast, increases in hippocampal neuro-
genesis along with exercise-induced increases in the levels of
brain-derived neurotrophic factor and reductions in b-amyloid load
led to improvements in memory. These findings suggest that hip-
pocampal neurogenesis could ameliorate AD, but only in the
presence of an optimal brain environment such as that induced by
physical exercise.9
A holistic view of AD development (vs the original “amyloid-
only” hypothesis) is needed, especially during the early phases of
this condition. In this context, an exercise milieu helps to combat
systemic inflammation and protect vascular health, both of which
might participate in the genesis of AD. There is a cross-talk be-
tween the muscle tissue and several organs including the brain,
with contracting muscles producing myriad myokines, that is,
cytokines or peptides (eg, interleukin-6, cathepsin B, irisin, among
many others), able to induce numerous health benefits at the
multisystemic level, such as an improved neurotrophism.10
More research is needed to establish new pharmacologic
treatments against AD, but this should not overshadow the
importance of lifestyle interventions, notably those focused on
regular PA, a “natural pill” that comes at a low price and largely free
of adverse effects.References
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